Showing results (661-670 of 5,681) with videos related to
Sort By:
Pageof 569
The Oncologist|September 12, 2020
Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602Tetsuji Terazawa, Takeshi Kato, Masahiro Goto, et al.The Oncologist|September 16, 2020
Can Oncologists Predict the Efficacy of Treatments in Randomized Trials?Daniel M Benjamin, David R Mandel, Tristan Barnes, et al.The Oncologist|September 20, 2020
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729)Melisa L Wong, Junheng Gao, Gita Thanarajasingam, et al.The Oncologist|August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case SeriesJacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.The Oncologist|August 28, 2020
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium StudyLi Yu, Menghan Shi, Qingqing Cai, et al.The Oncologist|April 15, 2006
Pegylated liposomal doxorubicin consolidation therapy after platinum/paclitaxel-based chemotherapy for suboptimally debulked, advanced-stage epithelial ovarian cancer patientsRodney P Rocconi, J Michael Straughn, Charles A Leath, et al.The Oncologist|April 15, 2006
Chemotherapeutic approaches for targeting cell death pathwaysM Stacey Ricci, Wei-Xing ZongThe Oncologist|April 15, 2006
Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancerDavid S EttingerThe Oncologist|April 15, 2006
The promise of the human papillomavirus vaccine does not confer immunity against ethical reflectionInmaculada de Melo-MartínThe Oncologist|March 30, 2004
Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphomaJulie M VosePageof 569